@article{JGO6864,
author = {Alica S. Sparling and Eunyoung Song and Heidi D. Klepin and Kristie L. Foley},
title = {Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid—enrolled colon cancer patients?},
journal = {Journal of Gastrointestinal Oncology},
volume = {7},
number = {3},
year = {2016},
keywords = {},
abstract = {Background: Adjuvant chemotherapy for colon cancer has been linked to patient and provider characteristics but little is known about whether distance to chemotherapy providers constitutes an obstacle to chemotherapy.
Methods: A total of 1,184 Medicaid patients diagnosed with colon cancer in North Carolina in 1999–2002 comprised the sample. Data from the N.C. Central Cancer Registry, N.C. Medicaid Claims, American Hospital Directory and US Census were merged. Logistic regression models were used to estimate the association between chemotherapy receipt and the distance to nearest chemotherapy provider.
Results: Compared to the referent group of SEER-staged II (local) cancer patients living less than 2 miles from the nearest chemotherapy provider, the odds of receiving chemotherapy fell as the distance to the nearest provider increased. The odds ratio (OR) for those living ≥5 to },
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/6864}
}